分子光谱市场-技术【核磁共振光谱（傅立叶变换NMR、固态NMR）、紫外-可见（双光束紫外-可见、单光束紫外-可见）、红外线、近红外线】、端-用户，全球预测（ 2024 - 2032）

Molecular Spectroscopy Market - Technology [Nuclear Magnetic Resonance Spectroscopy (Fourier-transform NMR, Solid-state NMR), UV-Visible (Dual-beam UV-visible, Single-beam UV-visible), Infrared, Near-infrared], End-user, Global Forecast (2024 - 2032)

出版日期: 2024年04月02日 | 出版商:

Global Market Insights Inc. | 英文 270 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于分析技术的技术进步和创新，分子光谱市场规模预计 2024 年至 2032 年间复合年增长率为 6%。快速的进步使研究人员能够在各个行业中进行更精确的分析。製药和生物技术领域的药物开发以及食品、饮料和环境监测的品质控制对分子成像的需求不断增长。例如，2023 年 10 月，TrinamiX GmbH 推出了由新的 Snapdragon(R) 8 Gen 3 参考设计提供支援的消费光谱解决方案。

研究人员的意识和接受度的提高以及新兴经济体製药和生物技术行业的扩张正在增加政府对研发活动的财政支持。对医疗基础设施的投资增加以及大学和研究机构对分子光谱仪器不断增长的需求也将推动市场成长。

分子光谱产业分为技术、最终用户和地区。

基于技术，由于红外光谱领域在各行业的多功能性，到 2032 年，其市场规模将出现显着的复合年增长率。红外光谱提供详细的分子分析和无损性质，使其在各个行业中至关重要。手持设备等技术的进步也促进了现场应用的使用。人们对製造流程分析技术 (PAT) 的兴趣日益浓厚，加上品质控制和保证的加强，将促进该细分市场的成长。

就最终用户而言，由于药物发现和开发程序越来越依赖先进的分析技术，CRO 领域的分子光谱市场预计将在 2024 年至 2032 年期间产生显着成长。 CRO 透过利用分子光谱技术进行快速且准确的诊断以及提高研究效率和缩短週转时间，为製药、生物技术和学术机构提供外包研究服务。

由于製药和生物技术产业的崛起，亚太地区分子光谱产业将在 2032 年实现持续成长。医疗保健基础设施投资的增加、政府研发措施的激增以及药品製造的扩张正在推动当地医药和生技产业的发展。太空方法也被用于食品和饮料（F&B）领域，用于品质控制、环境监测和科学研究，进一步推动区域市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 增加製药公司的应用和采用
  - 专注于新药研发的研发活动不断增加
  - 分子光谱领域的技术进步
- 产业陷阱与挑战
  - 分子光谱成本高
  - 专业知识和培训的要求
成长潜力分析
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按技术划分，2021 - 2032 年

主要趋势
核磁共振 (NMR) 光谱
- 傅立叶变换核磁共振波谱 (FTS)
- 固态核磁共振波谱 (SSNMR)
- 连续波 (CW) NMR 波谱
紫外可见光谱
- 双光束紫外可见光谱
- 单光束紫外可见光谱
- 基于阵列的紫外-可见光谱
红外线 (IR) 光谱
- 中波红外光谱
- 短波红外光谱
- 远波红外光谱
近红外光谱
- 傅立叶变换
- 扫描
- 过滤器或 AOTF
拉曼光谱
- 透过抽样技术
  - 表面增强拉曼散射
  - 尖端增强拉曼散射
  - 其他采样技术
- 按类型
  - 显微拉曼光谱
  - 基于探针的拉曼光谱
  - 傅立叶变换拉曼光谱
其他技术

第 6 章：市场估计与预测：按最终用户划分，2021 - 2032 年

主要趋势
製药和生物技术公司
学术及研究机构
合约研究组织
其他最终用户

第 7 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 8 章：公司简介

Agilent Technologies Inc.
Bruker Corporation
Danaher Corporation
Horiba Ltd.
Jasco Inc.
Jeol Ltd.
Merck KGaA
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
VIAVI Solutions Inc.

简介目录

Product Code: 8822

Molecular spectroscopy market size is anticipated to register 6% CAGR between 2024 and 2032, owing to technological advancements and innovations in analytical techniques. Rapid advancements have enabled researchers to conduct more precise analysis in various industries. There is growing demand for molecular imaging in pharmaceutical and biotech sectors for drug development, as well as in quality control across food, beverage, and environmental monitoring. To illustrate, in October 2023, TrinamiX GmbH launched its consumer spectroscopy solution powered by the new Snapdragon(R) 8 Gen 3 reference design.

Surging awareness and acceptance among researchers and the expansion of pharmaceutical and biotech industries in emerging economies is increasing the government financial support for R&D activities. Higher investments in healthcare infrastructure, and the rising demand for molecular spectroscopy instruments from universities and research institutes will also drive the market growth.

The molecular spectroscopy industry is classified into technology, end-user and region.

Based on technology, the market size from the infrared spectroscopy segment will witness significant CAGR through 2032, due to its versatility across various industries. Infrared spectroscopy offers detailed molecular analysis and non-destructive nature, making it crucial in various industries. Advances in technology like handheld devices are also boosting usage in field applications. Growing interest in process analysis technology (PAT) in manufacturing along with increased quality control and assurance will add to the segment growth.

With respect to end-user, the molecular spectroscopy market from the CROs segment is slated to generate notable gains during 2024-2032, due to increasing dependence on advanced analytical techniques for drug discovery and development procedure. CROs offer outsourced research services to pharmaceutical, biotech, and academic institutions by utilizing molecular spectroscopy technology for rapid and accurate diagnostics as well as enhancing research efficiency and reducing turnaround time.

Asia Pacific molecular spectroscopy industry will record sustained growth rate through 2032, attributed to rising pharmaceutical and biotechnology sector. Increased investments in healthcare infrastructure, surge in government initiatives for R&D, and expansion of pharmaceutical manufacturing are boosting the local medicine and biotech sector. Spatial methods are also being used in food & beverage (F&B) sector for quality control, environmental monitoring, and scientific research, further driving the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing application and adoption in pharmaceutical companies
  - 3.2.1.2 Rising research and development activities focusing on the creation of novel drugs
  - 3.2.1.3 Technological advancement in the field of molecular spectroscopy
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of molecular spectroscopy
  - 3.2.2.2 Requirement of specialized expertise and training
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Nuclear magnetic resonance (NMR) spectroscopy
- 5.2.1 Fourier-transform NMR spectroscopy (FTS)
- 5.2.2 Solid-state NMR spectroscopy (SSNMR)
- 5.2.3 Continuous-wave (CW) NMR spectroscopy
5.3 UV-visible spectroscopy
- 5.3.1 Dual-beam UV-visible spectroscopy
- 5.3.2 Single-beam UV-visible spectroscopy
- 5.3.3 Array-based UV-visible spectroscopy
5.4 Infrared (IR) spectroscopy
- 5.4.1 Mid-wave infrared spectroscopy
- 5.4.2 Short-wave infrared spectroscopy
- 5.4.3 Far-wave infrared spectroscopy
5.5 Near-infrared spectroscopy
- 5.5.1 Fourier-transform
- 5.5.2 Scanning
- 5.5.3 Filter or AOTF
5.6 Raman spectroscopy
- 5.6.1 By sampling technique
  - 5.6.1.1 Surface-enhanced Raman scattering
  - 5.6.1.2 Tip-enhanced Raman scattering
  - 5.6.1.3 Other sampling techniques
- 5.6.2 By type
  - 5.6.2.1 Micro-raman spectroscopy
  - 5.6.2.2 Probe-based raman spectroscopy
  - 5.6.2.3 Fourier tranform-raman spectroscopy
5.7 Other technologies

Chapter 6 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Pharmaceutical & biotechnology companies
6.3 Academic and research institutes
6.4 CROs
6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East and Africa